Skip to main content
Premium Trial:

Request an Annual Quote

MetriGenix, Sequenom

Premium

MetriGenix of Gaithersburg, Md., last week announced the launch of its 4D Array System of chips and instrumentation.

The product is an oligo array system based on MetriGenix “flow-through” design system biochips, with hybridization and detection stations.

The 4D Array System options include: a proliferation array, a chip designed to characterize the expression profiles of genes in cell cycle regulation; an inflammation array: oligo probes for genes associated with inflammatory response; a lung cancer array designed to distinguish adenocarcinoma, squamous cell carcinoma and normal lung samples; a breast cancer chip: a chip designed to characterize expression profiles of genes involved in the diseas; and a neural degeneration array.

The company said it will design and produce custom arrays. The system can contain from 50 to 192 probes per array, packaged in a cartridge system offered in a kit with 10 arrays and reagents.

 

Sequenom will use Gentra Systems’ Puragene DNA purification kits in all its MassARRAY products, including the new Allelotyping line, Gentra said last week.

Puragene is a system for purifying DNA for applications including Southern blotting and PCR.

Gentra Systems, Inc., based in Minneapolis, Minn., specializes in developing nucleic acid purification reagents and instruments for clinical and clinical research labs.

The company markets its products globally through direct sales and distributors.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.